Clinical Evidence Brief
Current state of evidence — preclinical, clinical, and investigational
Prepared March 2026
Proposed mechanisms
The biological rationale for combining dietary restriction with radiotherapy centers on the differential stress response.[1] Under conditions of nutrient deprivation, normal cells activate conserved protective pathways — reducing metabolic activity, upregulating stress resistance, and entering a quiescent state. Cancer cells, whose oncogenic mutations constitutively activate RAS, AKT, and mTOR signaling, are largely unable to make this shift; they remain metabolically active and, as a consequence, more vulnerable to radiation-induced damage. Concurrently, normal tissue is relatively protected — a divergence that forms the basis for combining fasting with radiotherapy.
The interaction between dietary restriction and androgen deprivation therapy (ADT) works through different mechanisms that depend on the class of ADT used, as described below. Separately, dietary restriction may also help counteract the metabolic side effects of ADT itself.
Time-restricted eating (TRE) — typically a 16:8 fasting-to-eating window — is among the more clinically feasible implementations of dietary restriction during active treatment, avoiding the weight loss and nutritional risk associated with sustained caloric restriction.[2] Transitioning from typical Western eating patterns to a sustained 16:8 window requires deliberate on-ramping; the author has written separately on a structured approach to this transition.[3]
(more…)
